Human Genome Epidemiology Literature Finder
|
Records 1 - 29 (of 29 Records) |
| Query Trace: Peritoneal Neoplasms and BRCA2[original query] |
|---|
| Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. The New England journal of medicine 2002 May 346 (21): 1609-15. Kauff Noah D, Satagopan Jaya M, Robson Mark E, Scheuer Lauren, Hensley Martee, Hudis Clifford A, Ellis Nathan A, Boyd Jeff, Borgen Patrick I, Barakat Richard R, Norton Larry, Castiel Mercedes, Nafa Khedoudja, Offit Kenne |
| Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 Mar 20 (5): 1260-8. Scheuer Lauren, Kauff Noah, Robson Mark, Kelly Bridget, Barakat Richard, Satagopan Jaya, Ellis Nathan, Hensley Martee, Boyd Jeff, Borgen Patrick, Norton Larry, Offit Kenne |
| Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. Journal of the National Cancer Institute 2003 Jul 95 (14): 1072-8. Rutter Joni L, Wacholder Sholom, Chetrit Angela, Lubin Flora, Menczer Joseph, Ebbers Sarah, Tucker Margaret A, Struewing Jeffery P, Hartge Patric |
| Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel. Gynecologic oncology 2003 Jun 89 (3): 494-8. Hirsh-Yechezkel G, Chetrit A, Lubin F, Friedman E, Peretz T, Gershoni R, Rizel S, Struewing J P, Modan |
| Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer. Cancer 2012 Aug 118 (15): 3703-9. Hyman David M, Zhou Qin, Iasonos Alexia, Grisham Rachel N, Arnold Angela G, Phillips Mary F, Bhatia Jasmine, Levine Douglas A, Aghajanian Carol, Offit Kenneth, Barakat Richard R, Spriggs David R, Kauff Noah |
| Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens. European journal of cancer (Oxford, England : 1990) 2013 Jan 49 (1): 132-41. Reitsma Welmoed, de Bock Geertruida H, Oosterwijk Jan C, Bart Joost, Hollema Harry, Mourits Marian J |
| Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012 May 22 (4): 579-85. Reitsma Welmoed, de Bock Geertruida H, Oosterwijk Jan C, ten Hoor Klaske A, Hollema Harry, Mourits Marian J |
| Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria. Clinical genetics 2014 Jan 85 (1): 72-5. Singer C F, Muhr D, Rappaport C, Tea M-K, Gschwantler-Kaulich D, Fink-Retter A, Pfeiler G, Berger A, Sun P, Narod S |
| Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 May 32 (15): 1547-53. Finch Amy P M, Lubinski Jan, Møller Pål, Singer Christian F, Karlan Beth, Senter Leigha, Rosen Barry, Maehle Lovise, Ghadirian Parviz, Cybulski Cezary, Huzarski Tomasz, Eisen Andrea, Foulkes William D, Kim-Sing Charmaine, Ainsworth Peter, Tung Nadine, Lynch Henry T, Neuhausen Susan, Metcalfe Kelly A, Thompson Islay, Murphy Joan, Sun Ping, Narod Steven |
| Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers. Familial cancer 2014 Jun 13 (2): 197-203. Chen Ying, Bancroft Elizabeth, Ashley Sue, Arden-Jones Audrey, Thomas Sarah, Shanley Susan, Saya Sibel, , Wakeling Emma, Eeles Rosali |
| A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study. Gynecologic oncology 2015 Jun 137 (3): 386-91. Coleman Robert L, Sill Michael W, Bell-McGuinn Katherine, Aghajanian Carol, Gray Heidi J, Tewari Krishnansu S, Rubin Steven C, Rutherford Thomas J, Chan John K, Chen Alice, Swisher Elizabeth |
| Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2017 12 28 (2): 308-315. Choi Min Chul, Jang Ja-Hyun, Jung Sang Geun, Park Hyun, Joo Won Duk, Song Seung Hun, Lee Chan, Lee Je |
| Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan. Journal of human genetics 2018 Apr 63 (4): 447-457. Arai Masami, Yokoyama Shiro, Watanabe Chie, Yoshida Reiko, Kita Mizuho, Okawa Megumi, Sakurai Akihiro, Sekine Masayuki, Yotsumoto Junko, Nomura Hiroyuki, Akama Yoshinori, Inuzuka Mayuko, Nomizu Tadashi, Enomoto Takayuki, Nakamura Sei |
| Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. The New England journal of medicine 2018 10 379 (26): 2495-2505. Moore Kathleen, Colombo Nicoletta, Scambia Giovanni, Kim Byoung-Gie, Oaknin Ana, Friedlander Michael, Lisyanskaya Alla, Floquet Anne, Leary Alexandra, Sonke Gabe S, Gourley Charlie, Banerjee Susana, Oza Amit, González-Martín Antonio, Aghajanian Carol, Bradley William, Mathews Cara, Liu Joyce, Lowe Elizabeth S, Bloomfield Ralph, DiSilvestro Pa |
| A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. Investigational new drugs 2018 1 36 (5): 828-835. van der Biessen Diane A J, Gietema Jourik A, de Jonge Maja J A, Desar Ingrid M E, den Hollander Martha W, Dudley Matthew, Dunbar Martin, Hetman Robert, Serpenti Camille, Xiong Hao, Mittapalli Rajendar K, Timms Kirsten M, Ansell Peter, Ratajczak Christine K, Shepherd Stacie Peacock, van Herpen Carla M |
| BRCA mutation in high grade epithelial ovarian cancers. Gynecologic oncology reports 2019 8 29 102-105. Manchana Tarinee, Phoolcharoen Natacha, Tantbirojn Pat |
| Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan. International journal of clinical oncology 2019 May . Nomura Hidetaka, Sekine Masayuki, Yokoyama Shiro, Arai Masami, Enomoto Takayuki, Takeshima Nobuhiro, Nakamura Sei |
| Prevalence of Tissue BRCA Gene Mutation in Ovarian, Fallopian Tube, and Primary Peritoneal Cancers: A Multi-Institutional Study. Asian Pacific journal of cancer prevention : APJCP 2020 Aug 21 (8): 2381-2388. Lertkhachonsuk Arb-Aroon, Suprasert Prapaporn, Manchana Tarinee, Kittisiam Thannaporn, Kantathavorn Nuttavut, Chansoon Tharintorn, Khunamornpong Surapan, Pohthipornthawat Natkrita, Tangjitgamol Siriwan, Luasiripanthu Taksa, Teerapakpinyo Chinachote, Shuangshot Shanop, Iemwimangsa Nareenart, Chantratita Was |
| The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study. Radiology and oncology 2020 May 54 (2): 180-186. Gornjec Andreja, Merlo Sebastijan, Novakovic Srdjan, Stegel Vida, Gazic Barbara, Perhavec Andraz, Blatnik Ana, Krajc Mate |
| Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention. Cancers 2020 5 12 (5): . Gaba Faiza, Blyuss Oleg, Liu Xinting, Goyal Shivam, Lahoti Nishant, Chandrasekaran Dhivya, Kurzer Margarida, Kalsi Jatinderpal, Sanderson Saskia, Lanceley Anne, Ahmed Munaza, Side Lucy, Gentry-Maharaj Aleksandra, Wallis Yvonne, Wallace Andrew, Waller Jo, Luccarini Craig, Yang Xin, Dennis Joe, Dunning Alison, Lee Andrew, Antoniou Antonis C, Legood Rosa, Menon Usha, Jacobs Ian, Manchanda Ranj |
| Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy: A Systematic Review. Obstetrics and gynecology 2020 2 135 (3): 498-508. Piedimonte Sabrina, Frank Cairina, Laprise Claudie, Quaiattini Andrea, Gotlieb Walter |
| Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels. International journal of cancer 2020 11 148 (5): 1155-1163. Crosbie Emma J, Flaum Nicola, Harkness Elaine F, Clayton Richard D, Holland Cathrine, Martin-Hirsch Pierre, Wood Nick, Keating Patrick, Woodward Emma R, Lalloo Fiona, Donnai Paul, Edmondson Richard J, Evans D Gare |
| Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline BRCA1/2 Mutation Carriers: A Retrospective Cohort Study. Yonsei medical journal 2021 11 62 (12): 1090-1097. Lim Hyunji, Kim Se Ik, Hyun Sowoon, Lee Gwang Bin, Seol Aeran, Lee Mar |
| The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit. BJOG : an international journal of obstetrics and gynaecology 2021 10 129 (3): 433-442. Frugtniet B, Morgan S, Murray A, Palmer-Smith S, White R, Jones R, Hanna L, Fuller C, Hudson E, Mullard A, Quinton A |
| Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without BRCA1 or BRCA2 Mutations. Journal of the advanced practitioner in oncology 2021 1 10 (5): 428-439. Garcia Andrew, Frahm Corey, Jeter Joanne M, Abraham Ivo, Chambers Setsuko K, Cragun Janiel M, McBride A |
| Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022 7 48 (12): 2539-2544. Marchetti Claudia, Arcieri Martina, Vertechy Laura, Ergasti Raffaella, Russo Giorgia, Zannoni Gian Franco, Minucci Angelo, Ercoli Alfredo, Scambia Giovanni, Fagotti An |
| Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 7 . Joanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, Lauren R Teras, Alpa V Patel, Chunling Hu, Siddhartha Yadav, Fergus J Couch, Shelley S Tworog |
| Homologous Recombination Deficiency Score Determined by Genomic Instability in a Romanian Cohort. Diagnostics (Basel, Switzerland) 2023 6 13 (11): . Viorica-Elena R?doi, Mihaela ?urcan, Ovidiu Virgil Maioru, Andra Dan, Laurentiu Camil Bohîl?ea, Elena Adriana Dumitrescu, Adelina Silvana Gheorghe, Dana Lucia St?nculeanu, Georgia Thodi, Yannis L Loukas, Ileana-Delia S?b |
| Incidence of Peritoneal Cancer Following Oophorectomy among BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute 2024 6 . Steven A Narod, Jacek Gronwald, Beth Karlan, Pal Moller, Tomasz Huzarski, Nadine Tung, Amber Aeilts, Andrea Eisen, Susan Randall Armel, Christian F Singer, William D Foulkes, Susan L Neuhausen, Olufunmilayo Olopade, Tuya Pal, Robert Fruscio, Kelly Metcalfe, Rebecca Raj, Michelle Jacobson, Ping Sun, Jan Lubinski, Joanne Kotsopoul |
- Page last reviewed:Feb 1, 2024
- Content source: